16 research outputs found

    Embedding Critique in the University: A New Role for Critical Marketing Education?

    Full text link
    This paper critically re-examines the role of the university as a site of (declining) social, cultural and political power and influence in the aftermath of the development of the „entrepreneurial university‟. Although scholars have identified the dangers of such a scenario, few attempts have been made to offer a pragmatic solution to preserve, or even rejuvenate, the university as an agent of critique. This paper proposes a novel answer by arguing that a critical marketing education can take over this role in the academy where traditional critical agents like the arts and humanities are widely acknowledged to have failed. Using a historical-critical approach, and by conceiving of „critique‟ as a heterogeneous, multidimensional amalgam of both business and the humanities, the paper shows how a critical marketing education offers a pragmatic means of preparing university students to become active and critical voices of society

    Quantitative sensory testing for assessment of somatosensory function in human oral mucosa: a review

    No full text
    <p><b>Objective:</b> This narrative review provides an overview of the quantitative sensory testing (QST) to assess somatosensory function in human oral mucosa.</p> <p><b>Material and methods:</b> A literature search was conducted in the PubMed database to identify studies <i>in vivo</i> on human oral mucosa using QST methods. A list of 149 articles was obtained and screened. A total of 36 relevant articles remained and were read in full text. Manual search of the reference lists identified eight additional relevant studies. A total of 44 articles were included for final assessment.</p> <p><b>Results:</b> The included studies were divided into six categories according to the study content and objective. In each category, there was a great variety of aims, methods, participants and outcome measures. The application of QST has nevertheless helped to monitor somatosensory function in experimental models of intraoral pain, effects of local anesthesia, after oral and maxillofacial surgery and after prosthodontic and orthodontic treatment.</p> <p><b>Conclusions:</b> QST has been proved to be sufficiently stable and reliable, and valuable information has been obtained regarding somatosensory function in healthy volunteers, special populations and orofacial pain patients. However, as most of the studies were highly heterogeneous, the results are difficult to compare quantitatively. A standardized intraoral QST protocol is recommended and expected to help advance a mechanism-based assessment of neuropathies and other intraoral pain conditions.</p

    Influence of Polymorphisms in the <i>HTR3A</i> and <i>HTR3B</i> Genes on Experimental Pain and the Effect of the 5-HT<sub>3</sub> Antagonist Granisetron

    No full text
    <div><p>The aim of this study was to investigate experimentally if 5-HT<sub>3</sub> single nucleotide polymorphisms (SNP) contribute to pain perception and efficacy of the 5-HT<sub>3</sub>-antagonist granisetron and sex differences. Sixty healthy participants were genotyped regarding <i>HTR3A (rs1062613)</i> and <i>HTR3B (rs1176744)</i>. First, pain was induced by bilateral hypertonic saline injections (HS, 5.5%, 0.2 mL) into the masseter muscles. Thirty min later the masseter muscle on one side was pretreated with 0.5 mL granisetron (1 mg/mL) and on the other side with 0.5 mL placebo (isotonic saline) followed by another HS injection (0.2 mL). Pain intensity, pain duration, pain area and pressure pain thresholds (PPTs) were assessed after each injection. HS evoked moderate pain, with higher intensity in the women (P = 0.023), but had no effect on PPTs. None of the SNPs influenced any pain variable in general, but compared to men, the pain area was larger in women carrying the C/C (<i>HTR3A</i>) (P = 0.015) and pain intensity higher in women with the A/C alleles (<i>HTR3B</i>) (P = 0.019). Pre-treatment with granisetron reduced pain intensity, duration and area to a lesser degree in women (P < 0.05), but the SNPs did not in general influence the efficacy of granisetron. Women carrying the C/T & T/T (<i>HTR3A</i>) genotype had less reduction of pain intensity (P = 0.041) and area (P = 0.005), and women with the C/C genotype (<i>HTR3B</i>) had less reduction of pain intensity (P = 0.030), duration (P = 0.030) and area compared to men (P = 0.017). In conclusion, SNPs did not influence experimental muscle pain or the effect of granisetron on pain variables in general, but there were some sex differences in pain variables that seem to be influenced by genotypes. However, due to the small sample size further research is needed before any firm conclusions can be drawn.</p></div

    Pain distribution in the masseter muscle after HS injection alone and after pre-treatment with granisetron.

    No full text
    <p>The figures show the pain distribution in the masseter muscle after injections of hypertonic saline (HS) alone (first injection) and after pre-treatment with granisetron (0.5 mL) and placebo (0.5 mL isotonic saline) followed by a second injection of hypertonic saline (second injection) in 60 healthy participants (30 women and 30 age-matched men). The pain area after HS injection did not differ significantly between sexes. The pain area was significantly smaller after pre-treatment with granisetron (P < 0.001) with greater reduction in men than women (P = 0.007).</p

    Flow chart of the experimental setting.

    No full text
    <p>The figure shows the time points (minutes) for the clinical examination, blood sampling, assessment of pain intensity (VAS), pressure pain thresholds (PPT), time points for injections and pain drawings. At the time point 0 minutes, bilateral injections of hypertonic saline (0.2 mL) into the masseter muscles were performed. At the time point 31 minutes, pre-treatment with granisetron (0.5 mL) on one side of the masseter muscle and placebo (0.5 mL) on the other side was done. Two minutes later, a second bilateral injection of hypertonic saline (0.2 mL) was performed. Pain intensity, pain duration and pain area were assessed after each injection.</p
    corecore